NCT00042588已完成2 期
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
The objective of this study is to demonstrate the safety and efficacy of IC14 in the treatment of hospitalized patients with community-acquired pneumonia and sepsis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Current diagnosis of community-acquired pneumonia.
- •Evidence of systemic inflammatory response to infection.
排除标准
- •Atypical or viral pneumonia based on clinical or epidemiologic suspicion by the investigator.
- •Presence of organ failure.
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)SchizophreniaParanoid SchizophreniaNCT00482430Merck Sharp & Dohme LLC50
已完成
2 期
TD-0903 for ALI Associated With COVID-19Acute Lung Injury (ALI) Associated With COVID-19Lung Inflammation Associated With COVID-19NCT04402866Theravance Biopharma235
终止
2 期
FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) StudyAlcohol Associated HepatitisNCT05639543Intercept Pharmaceuticals67
已完成
2 期
A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)Gastroesophageal Reflux DiseaseNCT02637557Ironwood Pharmaceuticals, Inc.282
已完成
2 期
Efficacy and Safety Study of MP-513 in Patients With Type 2 DiabetesType 2 DiabetesNCT00628212Tanabe Pharma Corporation324